Difficulty: Medium
Average Score: 67%
Practice
To evaluate the desired response of methylergonovine (Methergine), the nurse would assess the patient's
Correct answer
A
Rationale
In the context of pediatric respiratory distress, understanding the use of methylergonovine (Methergine) is crucial for nurses. Methylergonovine is a medication primarily used to manage postpartum hemorrhage by stimulating uterine contractions, thereby improving uterine tone. Therefore, the correct answer is A) uterine tone.
Option B) pain level is incorrect because methylergonovine is not used to assess or manage pain. Option C) blood pressure is incorrect as monitoring blood pressure is not the primary purpose of administering methylergonovine. Option D) last voiding is also incorrect as it is unrelated to the desired response of this medication.
In an educational context, nurses must be knowledgeable about the actions and expected outcomes of medications they administer. Understanding the specific effects of methylergonovine, such as assessing uterine tone, is essential to ensure safe and effective patient care. By selecting the correct answer, nurses can monitor and evaluate the therapeutic response of the medication accurately, promoting positive patient outcomes in scenarios where methylergonovine is utilized.
Option B) pain level is incorrect because methylergonovine is not used to assess or manage pain. Option C) blood pressure is incorrect as monitoring blood pressure is not the primary purpose of administering methylergonovine. Option D) last voiding is also incorrect as it is unrelated to the desired response of this medication.
In an educational context, nurses must be knowledgeable about the actions and expected outcomes of medications they administer. Understanding the specific effects of methylergonovine, such as assessing uterine tone, is essential to ensure safe and effective patient care. By selecting the correct answer, nurses can monitor and evaluate the therapeutic response of the medication accurately, promoting positive patient outcomes in scenarios where methylergonovine is utilized.